Aptorum Group Limited Announces Results of 2019 Annual General Meeting
November 15 2019 - 8:00AM
Business Wire
Aptorum Group Limited (Nasdaq: APM) (“the Company”) a
biopharmaceutical company focused on the development of novel
therapeutics to address certain global unmet medical needs,
announced today the results of its 2019 Annual General Meeting,
which was held on November 14, 2019, in Hong Kong.
At the Annual General Meeting, shareholders
- re-elected all of the Company’s current directors, namely Mr.
Ian Huen, Mr. Darren Lui, Dr. Clark Cheng, Dr. Justin Wu, Mr.
Charles Bathurst, Dr. Mirko Scherer and Professor Douglas Arner as
directors of the Company until the Company’s 2020 annual general
meeting or until their respective successors are duly appointed and
qualified; and
- approved, ratified and confirmed the re-appointment of Marcum
Bernsteun & Pinchuk LLP as the Company’s independent auditors
for the year ending December 31, 2019 and authorized the Board of
Directors to fix the remuneration of the auditors.
About Aptorum Group Limited
Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company
dedicated to developing and commercializing novel therapeutics to
tackle certain unmet medical needs. Aptorum Group is pursuing
therapeutic projects in neurology, infectious diseases,
gastroenterology, oncology and other disease areas.
For more information about Aptorum Group, please visit
www.aptorumgroup.com.
Disclaimer and Forward-Looking Statements
This press release includes statements concerning Aptorum Group
Limited and its future expectations, plans and prospects that
constitute “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995. For this purpose,
any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. In
some cases, you can identify forward-looking statements by terms
such as “may,” “should,” “expects,” “plans,” “anticipates,”
“could,” “intends,” “target,” “projects,” “contemplates,”
“believes,” “estimates,” “predicts,” “potential,” or “continue,” or
the negative of these terms or other similar expressions. Aptorum
Group has based these forward-looking statements largely on its
current expectations and projections about future events and trends
that it believes may affect its business, financial condition and
results of operations. These forward-looking statements speak only
as of the date of this press release and are subject to a number of
risks, uncertainties and assumptions including, without limitation,
risks related to its announced management and organizational
changes, the continued service and availability of key personnel,
its ability to expand its product assortments by offering
additional products for additional consumer segments, the company’s
anticipated growth strategies, anticipated trends and challenges in
its business, and its expectations regarding, and the stability of,
its supply chain, and the risks more fully described in Aptorum
Group’s Form 20-F and other filings that Aptorum Group may make
with the SEC in the future. Aptorum Group assumes no obligation to
update any forward-looking statements contained in this press
release as a result of new information, future events or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191115005085/en/
Investors: Tel: +852 2117 6611 Email:
investor.relations@aptorumgroup.com
Media: Tel: + 852 2117 6611 Email: info@aptorumgroup.com
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aptorum (NASDAQ:APM)
Historical Stock Chart
From Apr 2023 to Apr 2024